HQ Function

Served as the principal executive offices, overseeing corporate strategy, clinical development programs, financial operations, and investor relations for the publicly traded entity.

Notable Features:

The facility was a modern office space suited for a biotech company's corporate and administrative functions. Specific architectural highlights are not widely publicized, but it was part of a corporate park environment.

Work Culture:

As a clinical-stage oncology company, the culture likely emphasized innovation, scientific rigor, patient-centricity, and collaboration. Given its M&A activities, adaptability and a results-driven approach were also probable characteristics.

HQ Significance:

This headquarters was significant as it represented the U.S. base of operations for Ayala Pharmaceuticals, Inc. following its strategic merger with Advaxis, centralizing its leadership and efforts to advance its oncology pipeline in the U.S. market.

Values Reflected in HQ: The choice of a U.S. headquarters in a biotech hub like New Jersey likely reflected ambitions for growth, access to talent, and proximity to financial markets and collaborators.

Location:

Prior to its merger with Immunome, Ayala Pharmaceuticals had a primary presence in the United States (corporate headquarters, clinical trial operations) and Israel (significant research and development activities). Its clinical trials were also conducted internationally across various regions as needed for patient recruitment and regulatory purposes.

Street Address:

305 College Road East

City:

Princeton

State/Province:

New Jersey

Country:

USA